Diabetic papillopathy treated with intravitreal ranibizumab

7Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

In this report, we present a case of diabetic papillopathy that resolved after a single dose of intravitreal ranibizumab injection. A 50-year-old male presented with painless visual loss in his right eye. His visual acuity was 1/10 in the right eye and 10/10 in the left eye. Anterior segment examination of both eyes was unremarkable. Posterior segment of the right eye showed nonproliferative diabetic retinopathy with a swollen optic disc. Fluorescein angiography and optical coherence tomography were performed. There was dye leakage from the right optic disc. Optical coherence tomography revealed a significant increase in retinal nerve fiber layer thickness. Magnetic resonance imaging of the brain and orbit were normal. The patient received a single intravitreal ranibizumab (0.5 mg) injection. Two weeks after the injection, there was a marked regression of the disc swelling. Three months after the injection the optic disc was pallor and visual acuity was 6/10.

Cite

CITATION STYLE

APA

Yildirim, M., Kilic, D., Dursun, M. E., & Dursun, B. (2017). Diabetic papillopathy treated with intravitreal ranibizumab. International Medical Case Reports Journal, 10, 99–103. https://doi.org/10.2147/IMCRJ.S132479

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free